CG
ADPT icon

Caprock Group’s Adaptive Biotechnologies ADPT Stock Holding History

Caprock Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Hold
10,497
– – ﹤0.01% 1128
2026
Q1 		$146K Buy
10,497
+158
+2% +$2.52K ﹤0.01% 1067
2025
Q4 		$168K Sell
10,339
-568
-5% -$9.27K ﹤0.01% 1132
2025
Q3 		$144K Buy
+10,907
New +$133K ﹤0.01% 1087
2025
Q1 		$81.3K Buy
10,944
+529
+5% +$4.07K ﹤0.01% 1043
2024
Q4 		$62.4K Sell
10,415
-2,500
-19% -$13.8K ﹤0.01% 974
2024
Q3 		$66.1K Buy
12,915
+357
+3% +$1.55K ﹤0.01% 880
2024
Q2 		$45.5K Sell
12,558
-12,516
-50% -$39.7K ﹤0.01% 843
2024
Q1 		$80.5K Sell
25,074
-28
-0.1% -$108 ﹤0.01% 704
2023
Q4 		$123K Sell
25,102
-17
-0.1% -$78 0.01% 669
2023
Q3 		$137K Sell
25,119
-300
-1% -$1.98K 0.01% 627
2023
Q2 		$171K Hold
25,419
– – 0.01% 623
2023
Q1 		$224K Hold
25,419
– – 0.02% 569
2022
Q4 		$194K Sell
25,419
-1,919
-7% -$14.9K 0.02% 511
2022
Q3 		$195K Sell
27,338
-414
-1% -$3.9K 0.02% 523
2022
Q2 		$225K Sell
27,752
-4,586
-14% -$40.3K 0.02% 467
2022
Q1 		$449K Sell
32,338
-3,000
-8% -$47.2K 0.04% 318
2021
Q4 		$992K Sell
35,338
-10,700
-23% -$328K 0.08% 176
2021
Q3 		$1.56M Hold
46,038
– – 0.14% 103
2021
Q2 		$1.88M Sell
46,038
-3,000
-6% -$117K 0.17% 93
2021
Q1 		$1.97M Buy
49,038
+18,758
+62% +$1.02M 0.22% 76
2020
Q4 		$1.79M Sell
30,280
-10,430
-26% -$538K 0.2% 81
2020
Q3 		$1.98M Sell
40,710
-7,500
-16% -$315K 0.27% 66
2020
Q2 		$2.33M Hold
48,210
– – 0.35% 52
2020
Q1 		$1.34M Buy
48,210
+40,672
+540% +$1.13M 0.25% 77
2019
Q4 		$226K Buy
7,538
+38
+0.5% +$1.09K 0.04% 302
2019
Q3 		$232K Buy
+7,500
New +$306K 0.05% 287

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Caprock Group's ADPT Position: Q2 2026 in Review

Caprock Group held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 10,497 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Caprock Group first reported a position in ADPT in Q3 2019 and has held it in 27 quarters since. The position peaked at $2.33M in Q2 2020. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Caprock Group held 10,497 shares of Adaptive Biotechnologies worth $225K as of Q2 2026.
  • Caprock Group left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1128 holding.
  • Caprock Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 27 quarters since.
  • Caprock Group's Adaptive Biotechnologies position peaked at $2.33M in Q2 2020.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.